CXCL12 and atherosclerosis: In multivariate analysis, patients with higher levels of SDF1 (≥2.46 ng/mL) were 2 times more likely to have presented clinical atherosclerosis than patients with lower SDF1 levels [OR (95%CI): 2.3 (1.2–4.4), p = 0.012, Table 5].